This content is from: Features

Methods in enabling access to medicines

Adarsh Ramanujan of Lakshmikumaran & Sridharan describes the complex and delicate task of fixing the price of patented drugs in India

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial